In conclusion, our GWASs discovered SNPs and a gene that were associated with opioid analgesic requirements in the treatment of cancer pain, including the ANGPT1 rs1283671 and rs1283720 SNPs and SLC2A14 gene. Here, ANGPT1 is linked to cancer.